Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Remes

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Bone Marrow Transplantation|May 4, 2010
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftmentH E Johnsen, C Geisler, E Juvonen, et al.
Bone Marrow Transplantation|April 14, 2015
Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCTM Grövdal, H Nahi, G Gahrton, et al.
Leukemia|July 17, 1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia GroupE Elonen, A Almqvist, A Hänninen, et al.
European Journal of Haematology|February 14, 2004
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycleT Ruutu, E Koivunen, T Nousiainen, et al.
Leukemia|August 9, 2016
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemiaM Kontro, A Kumar, M M Majumder, et al.
Bone Marrow Transplantation|October 6, 2015
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myelomaR Silvennoinen, P Anttila, M Säily, et al.
Bone Marrow Transplantation|April 21, 2001
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)B Björkstrand, H Svensson, H Goldschmidt, et al.
Leukemia & Lymphoma|December 1, 1996
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell supportH E Johnsen, B Björkstrand, K Carlson, et al.
Blood|December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow TransplantationB B Björkstrand, P Ljungman, H Svensson, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Bone Marrow Transplantation|May 4, 2010
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftmentH E Johnsen, C Geisler, E Juvonen, et al.
Bone Marrow Transplantation|April 14, 2015
Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCTM Grövdal, H Nahi, G Gahrton, et al.
Leukemia|July 17, 1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia GroupE Elonen, A Almqvist, A Hänninen, et al.
European Journal of Haematology|February 14, 2004
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycleT Ruutu, E Koivunen, T Nousiainen, et al.
Leukemia|August 9, 2016
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemiaM Kontro, A Kumar, M M Majumder, et al.
Bone Marrow Transplantation|October 6, 2015
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myelomaR Silvennoinen, P Anttila, M Säily, et al.
Bone Marrow Transplantation|April 21, 2001
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)B Björkstrand, H Svensson, H Goldschmidt, et al.
Leukemia & Lymphoma|December 1, 1996
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell supportH E Johnsen, B Björkstrand, K Carlson, et al.
Blood|December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow TransplantationB B Björkstrand, P Ljungman, H Svensson, et al.
Pageof 12